Global Pharma-Grade Hyaluronic Acid Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
Page: 92
Published Date: 19 Sep 2024
Category: Pharma & Healthcare
PDF Download
Get FREE Sample
Customize Request
-
Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Description
Hyaluronic acid is a naturally occurring substance that helps retain moisture in the skin and eyes and lubricates the joints. Pharma-Grade Hyaluronic Acid is generally used in pharmaceutical formulations, such as Injection Product and Eye Drops for osteoarthritis of the knee joint.
Hyaluronic acid also called hyaluronan, is an anionic, nonsulfated glycosaminoglycan distributed widely throughout connective, epithelial, and neural tissues. It is unique among glycosaminoglycans in that it is nonsulfated, forms in the plasma membrane instead of the Golgi apparatus, and can be very large: human synovial HA averages about 7 million Da per molecule, or about 20000 disaccharide monomers, while other sources mention 3–4 million Da. As one of the chief components of the extracellular matrix, hyaluronan contributes significantly to cell proliferation and migration, and may also be involved in the progression of some malignant tumors. In this report, we only study the Pharma-Grade Hyaluronic Acid.
According to our (Global Info Research) latest study, the global Pharma-Grade Hyaluronic Acid market size was valued at US$ 188 million in 2023 and is forecast to a readjusted size of USD 370 million by 2030 with a CAGR of 10.1% during review period.
The rising preference rates and applications of hyaluronic acid products in dry eye and osteoarthritis management fuels the growth rate of the market significantly. the growing prevalence of osteoarthritis has fueled demand for hyaluronic acid-based treatments, as it is used in viscosupplementation injections to relieve joint pain. Rising consumer awareness of health, along with advancements in biotechnology, has further expanded the market's growth.
However, adverse effects associated with treatment or therapy such as redness and itching, as well as high production costs and regulatory hurdles. The process of extracting and purifying hyaluronic acid, particularly from natural sources, can be expensive, leading to higher product prices. Additionally, the stringent regulatory requirements for pharmaceutical-grade products create barriers for manufacturers, as they must meet rigorous standards for safety and efficacy. These factors can limit the entry of new players into the market and slow down overall growth.
Global key players of pharma-grade hyaluronic acid include Bloomage Biotech, HTL Biotechnology, Kewpie, Contipro, Fidia Farmaceutici, etc. The top five players hold a share about 78%. Europe is the largest market, has a share about 51%, followed by North America and Asia-Pacific , with share 26% and 21%, separately.
This report is a detailed and comprehensive analysis for global Pharma-Grade Hyaluronic Acid market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
Key Features:
Global Pharma-Grade Hyaluronic Acid market size and forecasts, in consumption value ($ Million), sales quantity (Kg), and average selling prices (US$/Kg), 2019-2030
Global Pharma-Grade Hyaluronic Acid market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Kg), and average selling prices (US$/Kg), 2019-2030
Global Pharma-Grade Hyaluronic Acid market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Kg), and average selling prices (US$/Kg), 2019-2030
Global Pharma-Grade Hyaluronic Acid market shares of main players, shipments in revenue ($ Million), sales quantity (Kg), and ASP (US$/Kg), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Pharma-Grade Hyaluronic Acid
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Pharma-Grade Hyaluronic Acid market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bloomage Biotech, AWA Biopharm, Kewpie, Contipro, Seikagaku, HTL Biotechnology, Fidia Farmaceutici, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Pharma-Grade Hyaluronic Acid market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Microbial Fermentation
Animal Tissue
Market segment by Application
Injection Product
Eye Drops
Major players covered
Bloomage Biotech
AWA Biopharm
Kewpie
Contipro
Seikagaku
HTL Biotechnology
Fidia Farmaceutici
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Pharma-Grade Hyaluronic Acid product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Pharma-Grade Hyaluronic Acid, with price, sales quantity, revenue, and global market share of Pharma-Grade Hyaluronic Acid from 2019 to 2024.
Chapter 3, the Pharma-Grade Hyaluronic Acid competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Pharma-Grade Hyaluronic Acid breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2019 to 2024.and Pharma-Grade Hyaluronic Acid market forecast, by regions, by Type, and by Application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Pharma-Grade Hyaluronic Acid.
Chapter 14 and 15, to describe Pharma-Grade Hyaluronic Acid sales channel, distributors, customers, research findings and conclusion.
Table of Contents
1 Market Overview
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Pharma-Grade Hyaluronic Acid Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Microbial Fermentation
1.3.3 Animal Tissue
1.4 Market Analysis by Application
1.4.1 Overview: Global Pharma-Grade Hyaluronic Acid Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Injection Product
1.4.3 Eye Drops
1.5 Global Pharma-Grade Hyaluronic Acid Market Size & Forecast
1.5.1 Global Pharma-Grade Hyaluronic Acid Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Pharma-Grade Hyaluronic Acid Sales Quantity (2019-2030)
1.5.3 Global Pharma-Grade Hyaluronic Acid Average Price (2019-2030)
2.1 Bloomage Biotech
2.1.1 Bloomage Biotech Details
2.1.2 Bloomage Biotech Major Business
2.1.3 Bloomage Biotech Pharma-Grade Hyaluronic Acid Product and Services
2.1.4 Bloomage Biotech Pharma-Grade Hyaluronic Acid Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Bloomage Biotech Recent Developments/Updates
2.2 AWA Biopharm
2.2.1 AWA Biopharm Details
2.2.2 AWA Biopharm Major Business
2.2.3 AWA Biopharm Pharma-Grade Hyaluronic Acid Product and Services
2.2.4 AWA Biopharm Pharma-Grade Hyaluronic Acid Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 AWA Biopharm Recent Developments/Updates
2.3 Kewpie
2.3.1 Kewpie Details
2.3.2 Kewpie Major Business
2.3.3 Kewpie Pharma-Grade Hyaluronic Acid Product and Services
2.3.4 Kewpie Pharma-Grade Hyaluronic Acid Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Kewpie Recent Developments/Updates
2.4 Contipro
2.4.1 Contipro Details
2.4.2 Contipro Major Business
2.4.3 Contipro Pharma-Grade Hyaluronic Acid Product and Services
2.4.4 Contipro Pharma-Grade Hyaluronic Acid Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Contipro Recent Developments/Updates
2.5 Seikagaku
2.5.1 Seikagaku Details
2.5.2 Seikagaku Major Business
2.5.3 Seikagaku Pharma-Grade Hyaluronic Acid Product and Services
2.5.4 Seikagaku Pharma-Grade Hyaluronic Acid Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Seikagaku Recent Developments/Updates
2.6 HTL Biotechnology
2.6.1 HTL Biotechnology Details
2.6.2 HTL Biotechnology Major Business
2.6.3 HTL Biotechnology Pharma-Grade Hyaluronic Acid Product and Services
2.6.4 HTL Biotechnology Pharma-Grade Hyaluronic Acid Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 HTL Biotechnology Recent Developments/Updates
2.7 Fidia Farmaceutici
2.7.1 Fidia Farmaceutici Details
2.7.2 Fidia Farmaceutici Major Business
2.7.3 Fidia Farmaceutici Pharma-Grade Hyaluronic Acid Product and Services
2.7.4 Fidia Farmaceutici Pharma-Grade Hyaluronic Acid Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Fidia Farmaceutici Recent Developments/Updates
3.1 Global Pharma-Grade Hyaluronic Acid Sales Quantity by Manufacturer (2019-2024)
3.2 Global Pharma-Grade Hyaluronic Acid Revenue by Manufacturer (2019-2024)
3.3 Global Pharma-Grade Hyaluronic Acid Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Pharma-Grade Hyaluronic Acid by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Pharma-Grade Hyaluronic Acid Manufacturer Market Share in 2023
3.4.3 Top 6 Pharma-Grade Hyaluronic Acid Manufacturer Market Share in 2023
3.5 Pharma-Grade Hyaluronic Acid Market: Overall Company Footprint Analysis
3.5.1 Pharma-Grade Hyaluronic Acid Market: Region Footprint
3.5.2 Pharma-Grade Hyaluronic Acid Market: Company Product Type Footprint
3.5.3 Pharma-Grade Hyaluronic Acid Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4.1 Global Pharma-Grade Hyaluronic Acid Market Size by Region
4.1.1 Global Pharma-Grade Hyaluronic Acid Sales Quantity by Region (2019-2030)
4.1.2 Global Pharma-Grade Hyaluronic Acid Consumption Value by Region (2019-2030)
4.1.3 Global Pharma-Grade Hyaluronic Acid Average Price by Region (2019-2030)
4.2 North America Pharma-Grade Hyaluronic Acid Consumption Value (2019-2030)
4.3 Europe Pharma-Grade Hyaluronic Acid Consumption Value (2019-2030)
4.4 Asia-Pacific Pharma-Grade Hyaluronic Acid Consumption Value (2019-2030)
4.5 South America Pharma-Grade Hyaluronic Acid Consumption Value (2019-2030)
4.6 Middle East & Africa Pharma-Grade Hyaluronic Acid Consumption Value (2019-2030)
5.1 Global Pharma-Grade Hyaluronic Acid Sales Quantity by Type (2019-2030)
5.2 Global Pharma-Grade Hyaluronic Acid Consumption Value by Type (2019-2030)
5.3 Global Pharma-Grade Hyaluronic Acid Average Price by Type (2019-2030)
6.1 Global Pharma-Grade Hyaluronic Acid Sales Quantity by Application (2019-2030)
6.2 Global Pharma-Grade Hyaluronic Acid Consumption Value by Application (2019-2030)
6.3 Global Pharma-Grade Hyaluronic Acid Average Price by Application (2019-2030)
7.1 North America Pharma-Grade Hyaluronic Acid Sales Quantity by Type (2019-2030)
7.2 North America Pharma-Grade Hyaluronic Acid Sales Quantity by Application (2019-2030)
7.3 North America Pharma-Grade Hyaluronic Acid Market Size by Country
7.3.1 North America Pharma-Grade Hyaluronic Acid Sales Quantity by Country (2019-2030)
7.3.2 North America Pharma-Grade Hyaluronic Acid Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8.1 Europe Pharma-Grade Hyaluronic Acid Sales Quantity by Type (2019-2030)
8.2 Europe Pharma-Grade Hyaluronic Acid Sales Quantity by Application (2019-2030)
8.3 Europe Pharma-Grade Hyaluronic Acid Market Size by Country
8.3.1 Europe Pharma-Grade Hyaluronic Acid Sales Quantity by Country (2019-2030)
8.3.2 Europe Pharma-Grade Hyaluronic Acid Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9.1 Asia-Pacific Pharma-Grade Hyaluronic Acid Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Pharma-Grade Hyaluronic Acid Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Pharma-Grade Hyaluronic Acid Market Size by Region
9.3.1 Asia-Pacific Pharma-Grade Hyaluronic Acid Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Pharma-Grade Hyaluronic Acid Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 South Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10.1 South America Pharma-Grade Hyaluronic Acid Sales Quantity by Type (2019-2030)
10.2 South America Pharma-Grade Hyaluronic Acid Sales Quantity by Application (2019-2030)
10.3 South America Pharma-Grade Hyaluronic Acid Market Size by Country
10.3.1 South America Pharma-Grade Hyaluronic Acid Sales Quantity by Country (2019-2030)
10.3.2 South America Pharma-Grade Hyaluronic Acid Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11.1 Middle East & Africa Pharma-Grade Hyaluronic Acid Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Pharma-Grade Hyaluronic Acid Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Pharma-Grade Hyaluronic Acid Market Size by Country
11.3.1 Middle East & Africa Pharma-Grade Hyaluronic Acid Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Pharma-Grade Hyaluronic Acid Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12.1 Pharma-Grade Hyaluronic Acid Market Drivers
12.2 Pharma-Grade Hyaluronic Acid Market Restraints
12.3 Pharma-Grade Hyaluronic Acid Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13.1 Raw Material of Pharma-Grade Hyaluronic Acid and Key Manufacturers
13.2 Manufacturing Costs Percentage of Pharma-Grade Hyaluronic Acid
13.3 Pharma-Grade Hyaluronic Acid Production Process
13.4 Industry Value Chain Analysis
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Pharma-Grade Hyaluronic Acid Typical Distributors
14.3 Pharma-Grade Hyaluronic Acid Typical Customers
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Table of Figures
List of Tables
Table 1. Global Pharma-Grade Hyaluronic Acid Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Pharma-Grade Hyaluronic Acid Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Bloomage Biotech Basic Information, Manufacturing Base and Competitors
Table 4. Bloomage Biotech Major Business
Table 5. Bloomage Biotech Pharma-Grade Hyaluronic Acid Product and Services
Table 6. Bloomage Biotech Pharma-Grade Hyaluronic Acid Sales Quantity (Kg), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Bloomage Biotech Recent Developments/Updates
Table 8. AWA Biopharm Basic Information, Manufacturing Base and Competitors
Table 9. AWA Biopharm Major Business
Table 10. AWA Biopharm Pharma-Grade Hyaluronic Acid Product and Services
Table 11. AWA Biopharm Pharma-Grade Hyaluronic Acid Sales Quantity (Kg), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. AWA Biopharm Recent Developments/Updates
Table 13. Kewpie Basic Information, Manufacturing Base and Competitors
Table 14. Kewpie Major Business
Table 15. Kewpie Pharma-Grade Hyaluronic Acid Product and Services
Table 16. Kewpie Pharma-Grade Hyaluronic Acid Sales Quantity (Kg), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Kewpie Recent Developments/Updates
Table 18. Contipro Basic Information, Manufacturing Base and Competitors
Table 19. Contipro Major Business
Table 20. Contipro Pharma-Grade Hyaluronic Acid Product and Services
Table 21. Contipro Pharma-Grade Hyaluronic Acid Sales Quantity (Kg), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Contipro Recent Developments/Updates
Table 23. Seikagaku Basic Information, Manufacturing Base and Competitors
Table 24. Seikagaku Major Business
Table 25. Seikagaku Pharma-Grade Hyaluronic Acid Product and Services
Table 26. Seikagaku Pharma-Grade Hyaluronic Acid Sales Quantity (Kg), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Seikagaku Recent Developments/Updates
Table 28. HTL Biotechnology Basic Information, Manufacturing Base and Competitors
Table 29. HTL Biotechnology Major Business
Table 30. HTL Biotechnology Pharma-Grade Hyaluronic Acid Product and Services
Table 31. HTL Biotechnology Pharma-Grade Hyaluronic Acid Sales Quantity (Kg), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. HTL Biotechnology Recent Developments/Updates
Table 33. Fidia Farmaceutici Basic Information, Manufacturing Base and Competitors
Table 34. Fidia Farmaceutici Major Business
Table 35. Fidia Farmaceutici Pharma-Grade Hyaluronic Acid Product and Services
Table 36. Fidia Farmaceutici Pharma-Grade Hyaluronic Acid Sales Quantity (Kg), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. Fidia Farmaceutici Recent Developments/Updates
Table 38. Global Pharma-Grade Hyaluronic Acid Sales Quantity by Manufacturer (2019-2024) & (Kg)
Table 39. Global Pharma-Grade Hyaluronic Acid Revenue by Manufacturer (2019-2024) & (USD Million)
Table 40. Global Pharma-Grade Hyaluronic Acid Average Price by Manufacturer (2019-2024) & (US$/Kg)
Table 41. Market Position of Manufacturers in Pharma-Grade Hyaluronic Acid, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 42. Head Office and Pharma-Grade Hyaluronic Acid Production Site of Key Manufacturer
Table 43. Pharma-Grade Hyaluronic Acid Market: Company Product Type Footprint
Table 44. Pharma-Grade Hyaluronic Acid Market: Company Product Application Footprint
Table 45. Pharma-Grade Hyaluronic Acid New Market Entrants and Barriers to Market Entry
Table 46. Pharma-Grade Hyaluronic Acid Mergers, Acquisition, Agreements, and Collaborations
Table 47. Global Pharma-Grade Hyaluronic Acid Consumption Value by Region (2019-2023-2030) & (USD Million) & CAGR
Table 48. Global Pharma-Grade Hyaluronic Acid Sales Quantity by Region (2019-2024) & (Kg)
Table 49. Global Pharma-Grade Hyaluronic Acid Sales Quantity by Region (2025-2030) & (Kg)
Table 50. Global Pharma-Grade Hyaluronic Acid Consumption Value by Region (2019-2024) & (USD Million)
Table 51. Global Pharma-Grade Hyaluronic Acid Consumption Value by Region (2025-2030) & (USD Million)
Table 52. Global Pharma-Grade Hyaluronic Acid Average Price by Region (2019-2024) & (US$/Kg)
Table 53. Global Pharma-Grade Hyaluronic Acid Average Price by Region (2025-2030) & (US$/Kg)
Table 54. Global Pharma-Grade Hyaluronic Acid Sales Quantity by Type (2019-2024) & (Kg)
Table 55. Global Pharma-Grade Hyaluronic Acid Sales Quantity by Type (2025-2030) & (Kg)
Table 56. Global Pharma-Grade Hyaluronic Acid Consumption Value by Type (2019-2024) & (USD Million)
Table 57. Global Pharma-Grade Hyaluronic Acid Consumption Value by Type (2025-2030) & (USD Million)
Table 58. Global Pharma-Grade Hyaluronic Acid Average Price by Type (2019-2024) & (US$/Kg)
Table 59. Global Pharma-Grade Hyaluronic Acid Average Price by Type (2025-2030) & (US$/Kg)
Table 60. Global Pharma-Grade Hyaluronic Acid Sales Quantity by Application (2019-2024) & (Kg)
Table 61. Global Pharma-Grade Hyaluronic Acid Sales Quantity by Application (2025-2030) & (Kg)
Table 62. Global Pharma-Grade Hyaluronic Acid Consumption Value by Application (2019-2024) & (USD Million)
Table 63. Global Pharma-Grade Hyaluronic Acid Consumption Value by Application (2025-2030) & (USD Million)
Table 64. Global Pharma-Grade Hyaluronic Acid Average Price by Application (2019-2024) & (US$/Kg)
Table 65. Global Pharma-Grade Hyaluronic Acid Average Price by Application (2025-2030) & (US$/Kg)
Table 66. North America Pharma-Grade Hyaluronic Acid Sales Quantity by Type (2019-2024) & (Kg)
Table 67. North America Pharma-Grade Hyaluronic Acid Sales Quantity by Type (2025-2030) & (Kg)
Table 68. North America Pharma-Grade Hyaluronic Acid Sales Quantity by Application (2019-2024) & (Kg)
Table 69. North America Pharma-Grade Hyaluronic Acid Sales Quantity by Application (2025-2030) & (Kg)
Table 70. North America Pharma-Grade Hyaluronic Acid Sales Quantity by Country (2019-2024) & (Kg)
Table 71. North America Pharma-Grade Hyaluronic Acid Sales Quantity by Country (2025-2030) & (Kg)
Table 72. North America Pharma-Grade Hyaluronic Acid Consumption Value by Country (2019-2024) & (USD Million)
Table 73. North America Pharma-Grade Hyaluronic Acid Consumption Value by Country (2025-2030) & (USD Million)
Table 74. Europe Pharma-Grade Hyaluronic Acid Sales Quantity by Type (2019-2024) & (Kg)
Table 75. Europe Pharma-Grade Hyaluronic Acid Sales Quantity by Type (2025-2030) & (Kg)
Table 76. Europe Pharma-Grade Hyaluronic Acid Sales Quantity by Application (2019-2024) & (Kg)
Table 77. Europe Pharma-Grade Hyaluronic Acid Sales Quantity by Application (2025-2030) & (Kg)
Table 78. Europe Pharma-Grade Hyaluronic Acid Sales Quantity by Country (2019-2024) & (Kg)
Table 79. Europe Pharma-Grade Hyaluronic Acid Sales Quantity by Country (2025-2030) & (Kg)
Table 80. Europe Pharma-Grade Hyaluronic Acid Consumption Value by Country (2019-2024) & (USD Million)
Table 81. Europe Pharma-Grade Hyaluronic Acid Consumption Value by Country (2025-2030) & (USD Million)
Table 82. Asia-Pacific Pharma-Grade Hyaluronic Acid Sales Quantity by Type (2019-2024) & (Kg)
Table 83. Asia-Pacific Pharma-Grade Hyaluronic Acid Sales Quantity by Type (2025-2030) & (Kg)
Table 84. Asia-Pacific Pharma-Grade Hyaluronic Acid Sales Quantity by Application (2019-2024) & (Kg)
Table 85. Asia-Pacific Pharma-Grade Hyaluronic Acid Sales Quantity by Application (2025-2030) & (Kg)
Table 86. Asia-Pacific Pharma-Grade Hyaluronic Acid Sales Quantity by Region (2019-2024) & (Kg)
Table 87. Asia-Pacific Pharma-Grade Hyaluronic Acid Sales Quantity by Region (2025-2030) & (Kg)
Table 88. Asia-Pacific Pharma-Grade Hyaluronic Acid Consumption Value by Region (2019-2024) & (USD Million)
Table 89. Asia-Pacific Pharma-Grade Hyaluronic Acid Consumption Value by Region (2025-2030) & (USD Million)
Table 90. South America Pharma-Grade Hyaluronic Acid Sales Quantity by Type (2019-2024) & (Kg)
Table 91. South America Pharma-Grade Hyaluronic Acid Sales Quantity by Type (2025-2030) & (Kg)
Table 92. South America Pharma-Grade Hyaluronic Acid Sales Quantity by Application (2019-2024) & (Kg)
Table 93. South America Pharma-Grade Hyaluronic Acid Sales Quantity by Application (2025-2030) & (Kg)
Table 94. South America Pharma-Grade Hyaluronic Acid Sales Quantity by Country (2019-2024) & (Kg)
Table 95. South America Pharma-Grade Hyaluronic Acid Sales Quantity by Country (2025-2030) & (Kg)
Table 96. South America Pharma-Grade Hyaluronic Acid Consumption Value by Country (2019-2024) & (USD Million)
Table 97. South America Pharma-Grade Hyaluronic Acid Consumption Value by Country (2025-2030) & (USD Million)
Table 98. Middle East & Africa Pharma-Grade Hyaluronic Acid Sales Quantity by Type (2019-2024) & (Kg)
Table 99. Middle East & Africa Pharma-Grade Hyaluronic Acid Sales Quantity by Type (2025-2030) & (Kg)
Table 100. Middle East & Africa Pharma-Grade Hyaluronic Acid Sales Quantity by Application (2019-2024) & (Kg)
Table 101. Middle East & Africa Pharma-Grade Hyaluronic Acid Sales Quantity by Application (2025-2030) & (Kg)
Table 102. Middle East & Africa Pharma-Grade Hyaluronic Acid Sales Quantity by Country (2019-2024) & (Kg)
Table 103. Middle East & Africa Pharma-Grade Hyaluronic Acid Sales Quantity by Country (2025-2030) & (Kg)
Table 104. Middle East & Africa Pharma-Grade Hyaluronic Acid Consumption Value by Country (2019-2024) & (USD Million)
Table 105. Middle East & Africa Pharma-Grade Hyaluronic Acid Consumption Value by Country (2025-2030) & (USD Million)
Table 106. Pharma-Grade Hyaluronic Acid Raw Material
Table 107. Key Manufacturers of Pharma-Grade Hyaluronic Acid Raw Materials
Table 108. Pharma-Grade Hyaluronic Acid Typical Distributors
Table 109. Pharma-Grade Hyaluronic Acid Typical Customers
List of Figures
Figure 1. Pharma-Grade Hyaluronic Acid Picture
Figure 2. Global Pharma-Grade Hyaluronic Acid Revenue by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Pharma-Grade Hyaluronic Acid Revenue Market Share by Type in 2023
Figure 4. Microbial Fermentation Examples
Figure 5. Animal Tissue Examples
Figure 6. Global Pharma-Grade Hyaluronic Acid Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 7. Global Pharma-Grade Hyaluronic Acid Revenue Market Share by Application in 2023
Figure 8. Injection Product Examples
Figure 9. Eye Drops Examples
Figure 10. Global Pharma-Grade Hyaluronic Acid Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 11. Global Pharma-Grade Hyaluronic Acid Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 12. Global Pharma-Grade Hyaluronic Acid Sales Quantity (2019-2030) & (Kg)
Figure 13. Global Pharma-Grade Hyaluronic Acid Price (2019-2030) & (US$/Kg)
Figure 14. Global Pharma-Grade Hyaluronic Acid Sales Quantity Market Share by Manufacturer in 2023
Figure 15. Global Pharma-Grade Hyaluronic Acid Revenue Market Share by Manufacturer in 2023
Figure 16. Producer Shipments of Pharma-Grade Hyaluronic Acid by Manufacturer Sales ($MM) and Market Share (%): 2023
Figure 17. Top 3 Pharma-Grade Hyaluronic Acid Manufacturer (Revenue) Market Share in 2023
Figure 18. Top 6 Pharma-Grade Hyaluronic Acid Manufacturer (Revenue) Market Share in 2023
Figure 19. Global Pharma-Grade Hyaluronic Acid Sales Quantity Market Share by Region (2019-2030)
Figure 20. Global Pharma-Grade Hyaluronic Acid Consumption Value Market Share by Region (2019-2030)
Figure 21. North America Pharma-Grade Hyaluronic Acid Consumption Value (2019-2030) & (USD Million)
Figure 22. Europe Pharma-Grade Hyaluronic Acid Consumption Value (2019-2030) & (USD Million)
Figure 23. Asia-Pacific Pharma-Grade Hyaluronic Acid Consumption Value (2019-2030) & (USD Million)
Figure 24. South America Pharma-Grade Hyaluronic Acid Consumption Value (2019-2030) & (USD Million)
Figure 25. Middle East & Africa Pharma-Grade Hyaluronic Acid Consumption Value (2019-2030) & (USD Million)
Figure 26. Global Pharma-Grade Hyaluronic Acid Sales Quantity Market Share by Type (2019-2030)
Figure 27. Global Pharma-Grade Hyaluronic Acid Consumption Value Market Share by Type (2019-2030)
Figure 28. Global Pharma-Grade Hyaluronic Acid Average Price by Type (2019-2030) & (US$/Kg)
Figure 29. Global Pharma-Grade Hyaluronic Acid Sales Quantity Market Share by Application (2019-2030)
Figure 30. Global Pharma-Grade Hyaluronic Acid Revenue Market Share by Application (2019-2030)
Figure 31. Global Pharma-Grade Hyaluronic Acid Average Price by Application (2019-2030) & (US$/Kg)
Figure 32. North America Pharma-Grade Hyaluronic Acid Sales Quantity Market Share by Type (2019-2030)
Figure 33. North America Pharma-Grade Hyaluronic Acid Sales Quantity Market Share by Application (2019-2030)
Figure 34. North America Pharma-Grade Hyaluronic Acid Sales Quantity Market Share by Country (2019-2030)
Figure 35. North America Pharma-Grade Hyaluronic Acid Consumption Value Market Share by Country (2019-2030)
Figure 36. United States Pharma-Grade Hyaluronic Acid Consumption Value (2019-2030) & (USD Million)
Figure 37. Canada Pharma-Grade Hyaluronic Acid Consumption Value (2019-2030) & (USD Million)
Figure 38. Mexico Pharma-Grade Hyaluronic Acid Consumption Value (2019-2030) & (USD Million)
Figure 39. Europe Pharma-Grade Hyaluronic Acid Sales Quantity Market Share by Type (2019-2030)
Figure 40. Europe Pharma-Grade Hyaluronic Acid Sales Quantity Market Share by Application (2019-2030)
Figure 41. Europe Pharma-Grade Hyaluronic Acid Sales Quantity Market Share by Country (2019-2030)
Figure 42. Europe Pharma-Grade Hyaluronic Acid Consumption Value Market Share by Country (2019-2030)
Figure 43. Germany Pharma-Grade Hyaluronic Acid Consumption Value (2019-2030) & (USD Million)
Figure 44. France Pharma-Grade Hyaluronic Acid Consumption Value (2019-2030) & (USD Million)
Figure 45. United Kingdom Pharma-Grade Hyaluronic Acid Consumption Value (2019-2030) & (USD Million)
Figure 46. Russia Pharma-Grade Hyaluronic Acid Consumption Value (2019-2030) & (USD Million)
Figure 47. Italy Pharma-Grade Hyaluronic Acid Consumption Value (2019-2030) & (USD Million)
Figure 48. Asia-Pacific Pharma-Grade Hyaluronic Acid Sales Quantity Market Share by Type (2019-2030)
Figure 49. Asia-Pacific Pharma-Grade Hyaluronic Acid Sales Quantity Market Share by Application (2019-2030)
Figure 50. Asia-Pacific Pharma-Grade Hyaluronic Acid Sales Quantity Market Share by Region (2019-2030)
Figure 51. Asia-Pacific Pharma-Grade Hyaluronic Acid Consumption Value Market Share by Region (2019-2030)
Figure 52. China Pharma-Grade Hyaluronic Acid Consumption Value (2019-2030) & (USD Million)
Figure 53. Japan Pharma-Grade Hyaluronic Acid Consumption Value (2019-2030) & (USD Million)
Figure 54. South Korea Pharma-Grade Hyaluronic Acid Consumption Value (2019-2030) & (USD Million)
Figure 55. India Pharma-Grade Hyaluronic Acid Consumption Value (2019-2030) & (USD Million)
Figure 56. Southeast Asia Pharma-Grade Hyaluronic Acid Consumption Value (2019-2030) & (USD Million)
Figure 57. Australia Pharma-Grade Hyaluronic Acid Consumption Value (2019-2030) & (USD Million)
Figure 58. South America Pharma-Grade Hyaluronic Acid Sales Quantity Market Share by Type (2019-2030)
Figure 59. South America Pharma-Grade Hyaluronic Acid Sales Quantity Market Share by Application (2019-2030)
Figure 60. South America Pharma-Grade Hyaluronic Acid Sales Quantity Market Share by Country (2019-2030)
Figure 61. South America Pharma-Grade Hyaluronic Acid Consumption Value Market Share by Country (2019-2030)
Figure 62. Brazil Pharma-Grade Hyaluronic Acid Consumption Value (2019-2030) & (USD Million)
Figure 63. Argentina Pharma-Grade Hyaluronic Acid Consumption Value (2019-2030) & (USD Million)
Figure 64. Middle East & Africa Pharma-Grade Hyaluronic Acid Sales Quantity Market Share by Type (2019-2030)
Figure 65. Middle East & Africa Pharma-Grade Hyaluronic Acid Sales Quantity Market Share by Application (2019-2030)
Figure 66. Middle East & Africa Pharma-Grade Hyaluronic Acid Sales Quantity Market Share by Country (2019-2030)
Figure 67. Middle East & Africa Pharma-Grade Hyaluronic Acid Consumption Value Market Share by Country (2019-2030)
Figure 68. Turkey Pharma-Grade Hyaluronic Acid Consumption Value (2019-2030) & (USD Million)
Figure 69. Egypt Pharma-Grade Hyaluronic Acid Consumption Value (2019-2030) & (USD Million)
Figure 70. Saudi Arabia Pharma-Grade Hyaluronic Acid Consumption Value (2019-2030) & (USD Million)
Figure 71. South Africa Pharma-Grade Hyaluronic Acid Consumption Value (2019-2030) & (USD Million)
Figure 72. Pharma-Grade Hyaluronic Acid Market Drivers
Figure 73. Pharma-Grade Hyaluronic Acid Market Restraints
Figure 74. Pharma-Grade Hyaluronic Acid Market Trends
Figure 75. Porters Five Forces Analysis
Figure 76. Manufacturing Cost Structure Analysis of Pharma-Grade Hyaluronic Acid in 2023
Figure 77. Manufacturing Process Analysis of Pharma-Grade Hyaluronic Acid
Figure 78. Pharma-Grade Hyaluronic Acid Industrial Chain
Figure 79. Sales Channel: Direct to End-User vs Distributors
Figure 80. Direct Channel Pros & Cons
Figure 81. Indirect Channel Pros & Cons
Figure 82. Methodology
Figure 83. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
-
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
-
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
-
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
Bloomage Biotech AWA Biopharm Kewpie Contipro Seikagaku HTL Biotechnology Fidia Farmaceutici
Related Reports
18 Mar 2023
Pharma & Healthcare
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>
